Product Information

AMIODARONE HCL 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1206 per EA under NDC 65862073260. Its NADAC has been published 515 times since Oct 12, 2016.

FDA first approved this application on Jun 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMIODARONE HCL 200 MG TABLET

Amiodarone Hydrochloride
$0.1206per EA

Strength

200 mg/1

NDC

65862073260

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AMIODARONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204742

FDA Approved

6/3/2016

TE Code

AB

On Market Since

6/3/2016

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for AMIODARONE HCL 200 MG TABLET has been published 515 times since Oct 12, 2016, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1206 per EA
All-time high$0.1561 (May 15, 2019)
All-time low$0.0989 (Nov 20, 2024)
52-week high$0.1227
52-week low$0.1160
Median price$0.1261
Average price$0.1264
Largest weekly change-17.6% (Apr 17, 2024)
Weeks tracked515
Tracking sinceOct 12, 2016

Price History

1W

+1.3%

1M

+1.3%

3M

+1.4%

6M

-0.5%

1Y

+2.5%

3Y

-1.1%

5Y

-12.0%

All

-10.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMIODARONE HCL 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1206 per EA (NDC 65862073260), effective Aug 19, 2026.

How has the price of AMIODARONE HCL 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for AMIODARONE HCL 200 MG TABLET has declined 10.7%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 200 MG TABLET?

Since Oct 12, 2016, the NADAC for AMIODARONE HCL 200 MG TABLET has ranged from a low of $0.0989 (Nov 20, 2024) to a high of $0.1561 (May 15, 2019), with a median of $0.1261 per EA.

Are there cheaper alternatives to AMIODARONE HCL 200 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMIODARONE HCL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures AMIODARONE HCL 200 MG TABLET?

AMIODARONE HCL 200 MG TABLET (NDC 65862073260) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.